Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 14, 2026, 3:21 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 865–888 of 1,489 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Standard Scheduling Clear all

Conditions: Cannabis Use, Adolescent Behavior
Interventions: Contingency Management; Behavioral
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 13 Years to 19 Years
Enrollment: 6 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Head and Neck Squamous Cell Carcinoma
Interventions: Stereotactic body radiotherapy, Traditional Palliation; Radiation
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 108 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Urinary Incontinence, Urinary Bladder, Overactive, Lower Urinary Tract Symptoms
Interventions: Preprocedure Telephone Call; Other
Lead sponsor: Boston Urogynecology Associates; Other
Eligibility: 18 Years and older · Female only
Enrollment: 130 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2017
U.S. locations: 1
States / cities: Cambridge, Massachusetts

Conditions: Cognitive Impairment, Long COVID
Interventions: Digital cognitive behavioral intervention-RxWell, Amphetamine-Dextroamphetamine; Behavioral · Drug
Lead sponsor: Eva Szigethy; Other
Eligibility: 21 Years to 65 Years
Enrollment: 7 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Ovarian Cancer, Epithelial, Peritoneal Cancer, Fallopian Tube Cancer
Interventions: Streamlined Education, Traditional Education; Behavioral
Lead sponsor: Duke University; Other
Eligibility: 18 Years and older · Female only
Enrollment: 64 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Back Pain
Interventions: SPRINT percutaneous peripheral nerve stimulator placed; Device
Lead sponsor: University of Utah; Other
Eligibility: 18 Years and older
Enrollment: 7 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Salt Lake City, Utah

Conditions: Overdose
Interventions: MI-CHANCE (TS + FTIR + MI), TS + FTIR + Flu and Hepatitis A Education; Behavioral
Lead sponsor: University of California, San Diego; Other
Eligibility: 18 Years and older
Enrollment: 588 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2029
U.S. locations: 1
States / cities: San Diego, California

Conditions: Prostate Cancer
Interventions: Not listed
Lead sponsor: University of Miami; Other
Eligibility: 30 Years and older · Male only
Enrollment: 144 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2032
U.S. locations: 1
States / cities: Miami, Florida

Conditions: Colonoscopy
Interventions: Golytely (polyethylene glycol), MiraLax (polyethylene glycol 3350); Drug
Lead sponsor: Oregon Health and Science University; Other
Eligibility: 50 Years to 90 Years
Enrollment: 432 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2010
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: Asthma, Asthma in Children
Interventions: Hospital to Home Transition (H2H); Behavioral
Lead sponsor: Kavita Parikh; Other
Eligibility: 4 Years to 12 Years
Enrollment: 340 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Washington D.C., District of Columbia

Conditions: Health Care Utilization
Interventions: Telecare; Other
Lead sponsor: Elizabeth K Rhodus; Other
Eligibility: 21 Years and older
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: Lexington, Kentucky

Conditions: Squamous Cell Carcinoma of Hypopharynx, Squamous Cell Carcinoma of Larynx, Squamous Cell Carcinoma of Oropharynx, Squamous Cell Carcinoma of Oral Cavity
Interventions: Scheduled IV Hydration, Clinician Assessment-Based IV Hydration; Other
Lead sponsor: West Virginia University; Other
Eligibility: 18 Years and older
Enrollment: 180 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 6
States / cities: Bridgeport, West Virginia • Martinsburg, West Virginia • Morgantown, West Virginia + 3 more

Conditions: Cirrhosis
Interventions: Health-IT +/- Scheduled Follow Up; Other
Lead sponsor: Virginia Commonwealth University; Other
Eligibility: 21 Years and older
Enrollment: 232 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2024
U.S. locations: 3
States / cities: Rochester, Minnesota • Richmond, Virginia

Conditions: Sunscreening Agents
Interventions: SPF 50 Y49 091 (BAY 987516), SPF 50 X15 158 (BAY 987516), SPF 50 X15 160 (BAY 987516), SPF 50 X57 162 (BAY 987516), J & J baby shampoo, X46 046 (control); Drug · Other
Lead sponsor: Bayer; Industry
Eligibility: 18 Years to 60 Years
Enrollment: 83 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015
U.S. locations: 1
States / cities: St. Petersburg, Florida

Conditions: Metastatic Renal Cell Carcinoma
Interventions: Exercise; Behavioral
Lead sponsor: Duke University; Other
Eligibility: 18 Years and older
Enrollment: 2 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Atrial Fibrillation
Interventions: No Amiodarone; Other
Lead sponsor: Inova Health Care Services; Other
Eligibility: 18 Years and older
Enrollment: 186 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2016
U.S. locations: 1
States / cities: Falls Church, Virginia

Conditions: Amyotrophic Lateral Sclerosis
Interventions: Mindfulness; Behavioral
Lead sponsor: Harvard University; Other
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2019
U.S. locations: 1
States / cities: Hershey, Pennsylvania

Conditions: Substance Use Disorders
Interventions: Community Support Intervention Group, Substance Use Disorder Educational Group; Behavioral
Lead sponsor: Johns Hopkins University; Other
Eligibility: 21 Years to 75 Years
Enrollment: 49 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Patellofemoral Pain
Interventions: Clinical Practice Guideline-adherent Care, Usual Care; Other
Lead sponsor: Sara Gorczynski, PT, DPT; Federal
Eligibility: 18 Years and older
Enrollment: 440 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 1
States / cities: San Diego, California

Conditions: Prostatic Neoplasms, Neoplasm Metastasis, Urogenital Neoplasms, Physiological Effects of Drugs, Antineoplastic Agents, Antineoplastic Agents, Hormonal, Androgens, Hormones, Hormones, Hormone Substitutes, and Hormone Antagonists, Abiraterone Acetate, Steroid Synthesis Inhibitors, Cytochrome P-450, Enzyme Inhibitors, Prednisone, Prednisolone, Cyclin-Dependent Kinase 4, Cyclin-Dependent Kinase 6
Interventions: Abemaciclib, Abiraterone, Prednisone or Prednisolone, Placebo for Abemaciclib; Drug
Lead sponsor: Eli Lilly and Company; Industry
Eligibility: 18 Years and older · Male only
Enrollment: 925 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2027
U.S. locations: 63
States / cities: Prescott, Arizona • Prescott Valley, Arizona • Tucson, Arizona + 57 more

Conditions: Breakthrough Nausea and Vomiting, Unspecified Adult Solid Tumor, Protocol Specific
Interventions: fosaprepitant dimeglumine, systemic chemotherapy, survey administration, quality-of-life assessment; Drug · Other · Procedure
Lead sponsor: OHSU Knight Cancer Institute; Other
Eligibility: 18 Years to 120 Years
Enrollment: 34 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2013
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: Stroke, Ischemic Stroke
Interventions: "Hopkins" post tPA for ischemic stroke monitoring protocol; Other
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years to 80 Years
Enrollment: 35 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2018
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Systemic Lupus Erythematosus, Rheumatoid Arthritis, Multiple Sclerosis, Autoimmune Diseases, Chronic Inflammatory Syndromes, Immune Dysregulation
Interventions: Low-Frequency Electromagnetic Resonance Therapy (LF-EMR), Sham Resonance Device (Inactive Control), Low-Dose Naltrexone (LDN); Device · Drug
Lead sponsor: Truway Health, Inc.; Industry
Eligibility: Not listed
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2034
U.S. locations: 1
States / cities: New York, New York

Conditions: Glioblastoma, Recurrent Glioblastoma
Interventions: RMC-5552; Drug
Lead sponsor: Nicholas Butowski; Other
Eligibility: 18 Years and older
Enrollment: 7 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: San Francisco, California

Search by objective public record fields.

Pilot Trial of Contingency Management for Long-Term Cannabis Abstinence

3-5 FrAction Stereotactic Body Radiation Therapy for Palliation of Head and Neck Squamous Cell Carcinoma: the FAST Phase II Randomized Trial

Urodynamic Testing: Can we Improve Patient Experience?

Addressing Cognitive Fog in Long-COVID-19 Patients

Prospective Randomized Trial of Streamlined Genetic Education and Testing for Ovarian Cancer Patients

Peripheral Nerve Stimulation for Back

Motivational Interviewing to Increase Uptake of Drug Checking and Safe Drug Use Behaviors to Reduce Overdose

Collection and Measurement of Biomarkers in Prostate Cancer Radiotherapy Patients

A Trial Comparing Bowel Preparation and Patient Tolerability of Miralax Versus Golytely

Hospital to Home Study: Trial to Optimize Transitions and Address Disparities in Asthma Care

Telecare in Rural Senior Centers

Scheduled IV Fluids in the Supportive Management of Patients Undergoing Chemo-radiotherapy for Head and Neck Cancer

Health IT Generated PROs to Improve Outcomes in Cirrhosis

To Evaluate Eye Installation-Tear Free

INTERVAL: Ipilimumab and Nivolumab Combination Therapy: A Study of a Supervised or Semi-Supervised Exercise InteRVention or Usual Care With Functional Capacity and Quality of Life Evaluations in Subjects With Advanced or Metastatic RenAL Cell Carcinoma

Necessity of Anti-Arrhythmic Medication After Surgical Ablation for Atrial Fibrillation

An Online Mindfulness Intervention for People With ALS and Their Caregivers

Activating Community Support for Substance Users

Evaluating the Effectiveness of Clinical Practice Guideline Adherence for Patellofemoral Pain

A Study of Abemaciclib (LY2835219) With Abiraterone in Men With Prostate Cancer That Has Spread to Other Parts of the Body and is Expected to Respond to Hormonal Treatment (Metastatic Hormone-Sensitive Prostate Cancer)

Fosaprepitant Dimeglumine in Treating Patients With Nausea and Vomiting Caused By Chemotherapy

Safety Study of Post Intravenous tPA Monitoring in Ischemic Stroke

Electromagnetic Immunotherapy Mapping and Cytokine Forecasting Study (QSIT)

RMC-5552 Monotherapy in Adult Subjects With Recurrent Glioblastoma